Aquamarine Financial (Cayman) Ltd

13D and 13G Filings

Issuer % of Class Filed
Schedule 13G · 2 securities · passive
Oramed Pharmaceuticals Inc. 13G/A
ORMP · 68403P203
6.4% 11/13/2026
Event 9/30/2026
Pulsenmore Ltd. 13G
PLSM · M8S7C5117
5.0% 10/8/2026
Event 3/31/2026

Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.